Evidence map›Paper›PMID 41152262›Full record

ArticleScientific reports2025

From hypothesis to robust evidence in a nationwide multicenter case-control study on 1490 women: milk stasis and idiopathic granulomatous mastitis.

Sadaf Alipour, Maryam Tabatabaian, Parissa Aziminezhadan, Paria Boloorinejad, Ali Orouji, Meraj Farbod, Nahid Nafissi, Fakhrolsadat Madani, Azin Saberi, Azita Mazinani and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sadaf AlipourBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam TabatabaianAnahid Clinic, Isfahan, Iran.
Parissa AziminezhadanAziminezhadan Breast Clinic, Tehran, Iran.
Paria BoloorinejadAnahid Clinic, Isfahan, Iran.
Ali OroujiDepartment of Nursing and Midwifery, TeMS.C., Islamic Azad University, Tehran, Iran.
Meraj FarbodDepartment of Surgery, Mortaz General Hospital, Yazd, Iran.
Nahid NafissiBreast Health & Cancer Research Center, Iran University of Medical Sciences, Tehran, Iran.
Fakhrolsadat MadaniDepartment of Infectious Diseases, Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Azin SaberiDepartment of Surgery, School of Medicine, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Azita MazinaniBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam DaneshpazhoohAutoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ramesh OmranipourBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Reza HosseinpourFaculty of Medicine Yasuj, Shahid Muftah Clinic 2, University of Medical Sciences, Yasuj, Iran.
Paniz FamilAmirAziminezhadan Breast Clinic, Tehran, Iran.
Maryam SarkardehBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahsa TavakolBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abdolali AssarianDepartment of Surgery, School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Bita EslamiBreast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. dr.bes.96@gmail.com.

Funding

Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran 1402-2-417-67494
6 · The paper itself

Abstract

Idiopathic granulomatous mastitis (IGM) is rare globally and infrequent in some middle-east regions. Sex-hormonal factors have been mentioned as predisposing factors for IGM, recent large-sale studies indicate a 7.5-fold increased risk in women who have breastfed. This study investigates BF-related factors that contribute to IGM development. We conducted a multicenter case-control study and recorder BF-related events in 730 IGM patients and healthy 760 controls. The mean age of participants was 36.63 ± 6.49 in the Case and 36.96 ± 6.11 years in the Control Group (p = 0.31). IGM occurred more frequently in the contralateral breast in one-sided BF (p < 0.001), with discordance between the affected side and BF side in 68.3% of cases (p = 0.005). Multivariate analysis revealed significant associations between IGM and one-sided BF (OR = 4.21), post-weaning breast engorgement (OR = 3.06), lactational mastitis (OR = 1.93), and oral medication use for infants (OR = 2.59). The study achieved 100% statistical power for both primary and secondary objectives, with narrow confidence intervals indicating high precision. This study provides robust evidence supporting the milk stasis hypothesis, demonstrating that BF-related issues leading to milk stasis are strongly associated with IGM development. Preventive strategies to minimize milk stasis and encourage bilateral BF may help reduce IGM risk.

Indexed as

Breast FeedingGranulomatous MastitisMilk, HumanAdultCase-Control StudiesFemaleHumansLactationMiddle AgedRisk FactorsGalactostasisGranulomatous lobular mastitisHealthy breastfeedingIGMLactationMilk stasis

Identifiers

PMID41152262
PMCPMC12569042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.